Stifel lowered the firm’s price target on Idexx Laboratories (IDXX) to $420 from $450 and keeps a Hold rating on the shares following survey work focused on recent innovation from the major Animal Health players.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IDXX: